General & Plastic Surgery Devices - EMEA

  • EMEA
  • The General & Plastic Surgery Devices market market in the Europe, Middle East, and Africa (in Europe, the Middle East, and Africa) region is anticipated to achieve a revenue of US$9.88bn by the year 2024.
  • The market is projected to display a steady annual growth rate (CAGR 2024-2029) of 4.93%, leading to a market volume of US$12.57bn by 2029.
  • When compared globally, the United States is expected to generate the highest revenue, amounting to US$9,844.00m in 2024.
  • In the EMEA region, Germany is experiencing a growing demand for General & Plastic Surgery Devices, driven by advancements in technology and a rising aging population.

Key regions: Europe, Japan, United Kingdom, Netherlands, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The General & Plastic Surgery Devices market in EMEA is experiencing steady growth due to increasing customer preferences for cosmetic procedures, advancements in technology, and favorable local special circumstances in certain countries. Customer preferences for cosmetic procedures have been a major driver of growth in the General & Plastic Surgery Devices market in EMEA. The desire to enhance one's appearance and improve self-confidence has led to a growing demand for surgical and non-surgical cosmetic procedures. This trend is particularly prevalent among the younger population who are more open to trying new aesthetic treatments. Additionally, the increasing acceptance of cosmetic procedures as a means of self-care and personal grooming has further fueled the demand for General & Plastic Surgery Devices in the region. Advancements in technology have also played a significant role in the growth of the General & Plastic Surgery Devices market in EMEA. The development of innovative surgical techniques and the introduction of minimally invasive procedures have made cosmetic surgeries safer, more efficient, and less invasive. This has not only reduced the recovery time for patients but has also attracted a larger customer base who may have been hesitant to undergo traditional surgical procedures. Furthermore, technological advancements in imaging and visualization tools have improved the accuracy and precision of surgical procedures, leading to better outcomes for patients. Certain countries in EMEA have favorable local special circumstances that have contributed to the growth of the General & Plastic Surgery Devices market. For example, countries such as Germany and France have a high disposable income and a strong healthcare infrastructure, making them attractive markets for General & Plastic Surgery Devices. These countries also have a well-established medical tourism industry, attracting patients from neighboring countries who seek high-quality cosmetic procedures at a lower cost. Additionally, social media and the influence of celebrities have played a role in increasing the demand for cosmetic procedures in certain countries, as individuals aspire to achieve a certain aesthetic look. Underlying macroeconomic factors such as population growth, urbanization, and increasing healthcare expenditure have also contributed to the growth of the General & Plastic Surgery Devices market in EMEA. The region has witnessed a growing population, particularly in urban areas, which has led to a larger customer base for cosmetic procedures. Moreover, the rising healthcare expenditure in EMEA countries has enabled individuals to afford cosmetic procedures and invest in their appearance. In conclusion, the General & Plastic Surgery Devices market in EMEA is experiencing steady growth due to increasing customer preferences for cosmetic procedures, advancements in technology, favorable local special circumstances, and underlying macroeconomic factors. As the demand for aesthetic treatments continues to rise, the market is expected to further expand in the coming years.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)